NextBio

Help
Description: The N-acetyl derivative of cysteine. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates. [PubChem]
Drug Type: Small Molecule; Approved
Pharmacology: Acetylcysteine has been shown to reduce the extent of liver injury following acetaminophen overdose. It is most effective when given early, with benefit seen principally in patients treated within 8-10 hours of the overdose. Acetylcysteine likely protects the liver by maintaining or restoring the glutathione levels, or by acting as an alternate substrate for conjugation with, and thus detoxification of, the reactive metabolite.
Mechanism of Action: Acetylcysteine may protect against acetaminophen overdose-induced hepatotoxicity by maintaining or restoring hepatic concentrations of glutathione. Glutathione is required to inactivate an intermediate metabolite of acetaminophen that is thought to be hepatotoxic. In acetaminophen overdose, excessive quantities of this metabolite are formed because the primary metabolic (glucuronide and sulfate conjugation) pathways become saturated. Acetylcysteine may act by reducing the metabolite to the parent compound and/or by providing sulfhydryl for conjugation of the metabolite. Experimental evidence also suggests that a sulfhydryl-containing compound such as acetylcysteine may also directly inactivate the metabolite. Inhalation - Acetylcysteine exerts its mucolytic action through its free sulfhydryl group, which opens the disulfide bonds and lowers mucus viscosity. This action increases with increasing pH and is most significant at pH 7 to 9. The mucolytic action of acetylcysteine is not affected by the presence of DNA.
Indication: Used mainly as a mucolytic and in the management of paracetamol (acetaminophen) overdose.
Half Life: 5.6 hours (adults), 11 hours (neonates)
View Complete Description




Individual Studies
  • β-adrenergic agonist isoproterenol-induced tachycardia and myocardial necrosis

    Rattus norvegicus Rattus norvegicus | RNA Expression   RNA Expression

    Gene expression was evaluated in the myocardium of male Wistar rats after a single sc administration of 0.5 mg of isoproterenol, a β-adrenergic agonist that causes acute tachycardia with subsequent myocardial necrosis.

    Authors: Mikaelian I, Kanwal C

    Organization: Hoffman-La Roche RIGG 340 Kingsland Stre…

  • RAW 264.7 cells treated with LPS, ISO, PGE2, LPS+ISO and LPS+PGE2

    Mus musculus Mus musculus | RNA Expression   RNA Expression

    Characterization of modulation of TLR ligands by non-TLR ligands using murine RAW 264.7 cells by treating with with LPS, IFN-gamma, 2-methyl-thio-ATP (2MA), PGE(2), and isoproterenol (ISO).

    Authors: Zhu Xiaocui, Chang MiSook, Hsueh Robert et al.

    Organization: California Institute of Technology Biolo…

View All Individual Studies

Thought leaders and organizations working on research involving n-acetylcysteine.

  • Peter W Kalivas
  • Haoqian Chen
  • M Foster Olive
  • Martin Posch
  • F Bendtsen
  • Yale University
  • National Institute on Drug Abuse (NIDA)
  • Medical University of South Carolina
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDD…
  • Minneapolis Veterans Affairs Medical Center
  • Medical University of South Carolina
  • Baylor College of Medicine
  • Panjab University
  • University of Texas Southwestern Medical Center
  • Ewha Womans University 911-1 Mok-6-dong

Clinical Trials | 166 trials

Help for Clinical Trials View All

News | 5 stories

Help for News View All

Community

Help for Community
  • No NextBio users were found for “n-acetylcysteine”.
    Complete your user profile with your interests, if you want others to find you within the NextBio community.

  • No NextBio groups were found for “n-acetylcysteine”.
    Be the first to start a group and share your interests with others within the NextBio community.